ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

ENVB Enveric Biosciences Inc

0.9209
-0.0191 (-2.03%)
01 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Enveric Biosciences Inc ENVB NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.0191 -2.03% 0.9209 18:34:06
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.955 0.901 0.955 0.9298 0.94
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/3/202406:00BWEnveric Biosciences Reports Financial Results and Provides..
19/3/202406:00BWEnveric Biosciences Signs Non-Binding Term Sheets to Pursue..
12/3/202406:00BWEnveric Biosciences Announces New Patent Issuances..
11/3/202411:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/3/202407:00EDGAR2Form 8-K - Current report
29/2/202406:00EDGAR2Form 8-K - Current report
29/2/202406:00BWEnveric Biosciences Signs Non-Binding Term Sheets to Pursue..
26/2/202415:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202415:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202407:00BWEnveric Biosciences Agrees to Sell Cancer-Targeting..
21/2/202407:05EDGAR2Form 8-K - Current report
21/2/202407:00BWEnveric Biosciences Unveils Library of Preclinical Compounds..
14/2/202414:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202407:05EDGAR2Form 8-K - Current report
06/2/202409:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202416:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202407:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
11/1/202415:43EDGAR2Form S-3 - Registration statement under Securities Act of..
08/1/202415:42EDGAR2Form 8-K - Current report
03/1/202407:05EDGAR2Form 8-K - Current report
29/12/202315:43EDGAR2Form 8-K - Current report
29/12/202307:52BWEnveric Biosciences Announces Exercise of Warrants and..
28/12/202307:05EDGAR2Form 8-K - Current report
28/12/202307:00BWEnveric Biosciences Selects EB-003 as Lead Drug Candidate..
27/12/202307:05EDGAR2Form 8-K - Current report
27/12/202307:00BWEnveric Biosciences Reports Year End Progress for..
20/12/202307:00BWEnveric Biosciences to Participate in Biotech Showcase 2024..
06/12/202315:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
05/12/202307:05EDGAR2Form 8-K - Current report
05/12/202307:00BWEnveric Biosciences Selects Development Candidates from..
01/12/202315:31EDGAR2Form S-1/A - General form for registration of securities..
29/11/202307:18EDGAR2Form 8-K - Current report
29/11/202307:00BWEnveric Biosciences Receives Notice of Allowance from USPTO..
27/11/202307:00BWEnveric Biosciences Announces Manuscript Describing the..
24/11/202307:00BWEnveric Biosciences Announces Presentation of Two Posters at..
22/11/202315:30EDGAR2Form 8-K - Current report
13/11/202315:10EDGAR2Form 8-K - Current report
13/11/202315:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:01BWEnveric Biosciences Reports Third Quarter 2023 Corporate and..
06/11/202307:05EDGAR2Form 8-K - Current report
02/11/202316:29EDGAR2Form 8-K - Current report
31/10/202307:05EDGAR2Form 8-K - Current report
31/10/202307:00BWEnveric Biosciences Receives Notice of Allowance from USPTO..
20/10/202307:05EDGAR2Form 8-K - Current report
20/10/202307:00BWEnveric Biosciences to Present at the Centurion One 5th..
18/10/202307:05EDGAR2Form 8-K - Current report
18/10/202307:00BWEnveric Biosciences Initiates GLP Toxicology & Safety..
11/10/202307:05EDGAR2Form 8-K - Current report

Su Consulta Reciente

Delayed Upgrade Clock